Home/Filings/4/0001104659-20-004761
4//SEC Filing

Kaufman Michael J. 4

Accession 0001104659-20-004761

CIK 0001442836other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 4:31 PM ET

Size

7.7 KB

Accession

0001104659-20-004761

Insider Transaction Report

Form 4
Period: 2020-01-15
Kaufman Michael J.
Sr VP Chmistry, Man & Control
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-15+120,000120,000 total
    Exercise: $6.16Exp: 2030-01-15Common Stock (120,000 underlying)
  • Award

    Restricted Stock Units

    2020-01-15+26,66726,667 total
    Common Stock (26,667 underlying)
Footnotes (3)
  • [F1]The options vest in equal quarterly installments over the first four years after the vesting commencement date, January 15, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F3]The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 15, 2020.

Documents

1 file

Issuer

Mersana Therapeutics, Inc.

CIK 0001442836

Entity typeother

Related Parties

1
  • filerCIK 0001709996

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:31 PM ET
Size
7.7 KB